The overarching goals of the Genetic Disorders of Mucociliary Clearance Consortium (GDMCC) Administrative Core is to provide comprehensive and sustained administrative, logistical, and operational support for all investigators, team members, trainees, and our patient advocacy groups. These goals will lead to successful completion of projects that will advance our understanding of the genetic bases, pathophysiology and clinical course of rare, chronic suppurative respiratory disease, specifically primary ciliary dyskinesia and primary immunodeficiencies; improve diagnostic capabilities; and identify novel therapeutic targets and endpoints for clinical trials that will ultimately improve outcomes for these affected individuals.
The specific aims of the Administrative Core are: 1) To provide excellent and comprehensive operational and organizational administration of the Consortium; 2) Mandate and facilitate regular, meaningful communications and coordination between all collaborating investigators and institutions; 3) Establish and maintain strong, productive working relationships with collaborators, patient and stakeholder groups, the NIH and serve as a point of coordination with the biostatisticians, Rare Diseases Clinical Research Network and the Data Management and Coordinating Center; 4) Ensure and promote awareness of the GDMCC to the clinical, scientific, and relevant patient and stakeholder communities; and 5) Recruit and regularly communicate with an External Advisory Committee consisting of scientific, clinical, and patient-stakeholder representatives. By achieving these aims, the GDMCC will successfully continue to improve the outcomes of patients with primary ciliary dyskinesia and primary immunodeficiencies.
|Horani, Amjad; Ferkol, Thomas W (2018) Advances in the Genetics of Primary Ciliary Dyskinesia: Clinical Implications. Chest 154:645-652|
|Metersky, Mark L; Aksamit, Timothy R; Barker, Alan et al. (2018) The Prevalence and Significance of Staphylococcus aureus in Patients with Non-Cystic Fibrosis Bronchiectasis. Ann Am Thorac Soc 15:365-370|
|Rosenfeld, Margaret; Ostrowski, Lawrence E; Zariwala, Maimoona A (2018) Primary ciliary dyskinesia: keep it on your radar. Thorax 73:101-102|
|Goutaki, Myrofora; Halbeisen, Florian S; Spycher, Ben D et al. (2017) Growth and nutritional status, and their association with lung function: a study from the international Primary Ciliary Dyskinesia Cohort. Eur Respir J 50:|
|Bustamante-Marin, Ximena M; Ostrowski, Lawrence E (2017) Cilia and Mucociliary Clearance. Cold Spring Harb Perspect Biol 9:|
|Lucas, Jane S; Barbato, Angelo; Collins, Samuel A et al. (2017) European Respiratory Society guidelines for the diagnosis of primary ciliary dyskinesia. Eur Respir J 49:|
|Behan, Laura; Leigh, Margaret W; Dell, Sharon D et al. (2017) Validation of a health-related quality of life instrument for primary ciliary dyskinesia (QOL-PCD). Thorax 72:832-839|
|Kristof, Arnold S; Petrof, Basil J; Hamid, Qutayba et al. (2017) An Official American Thoracic Society Workshop Report: Translational Research in Rare Respiratory Diseases. Ann Am Thorac Soc 14:1239-1247|
|Shapiro, Adam J; Leigh, Margaret W (2017) Value of transmission electron microscopy for primary ciliary dyskinesia diagnosis in the era of molecular medicine: Genetic defects with normal and non-diagnostic ciliary ultrastructure. Ultrastruct Pathol 41:373-385|
|Blackburn, Kevin; Bustamante-Marin, Ximena; Yin, Weining et al. (2017) Quantitative Proteomic Analysis of Human Airway Cilia Identifies Previously Uncharacterized Proteins of High Abundance. J Proteome Res 16:1579-1592|
Showing the most recent 10 out of 64 publications